Related references
Note: Only part of the references are listed.LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p
Zhang Aichen et al.
APOPTOSIS (2021)
Review article: new therapeutic interventions for advanced hepatocellular carcinoma
Saroja Bangaru et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway
Qinyang Xu et al.
EBIOMEDICINE (2020)
Different Mechanisms of Action of Regorafenib and Lenvatinib on Toll-Like Receptor-Signaling Pathways in Human Hepatoma Cell Lines
Reina Sasaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
miR-142-5p promotes renal cell tumorigenesis by targeting TFAP2B
Maoshu Zhu et al.
ONCOLOGY LETTERS (2020)
MiR-142-5p Suppresses Lung Cancer Cell Metastasis by Targeting Yin Yang 1 to Regulate Epithelial-Mesenchymal Transition
Qiao Zhang et al.
CELLULAR REPROGRAMMING (2020)
High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo
Yuji Ikeda et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2020)
miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes
Xiaodi Li et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
Jens Ricke et al.
JOURNAL OF HEPATOLOGY (2019)
Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies
Ali Alqahtani et al.
MEDICINA-LITHUANIA (2019)
MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells
Reto S. Kohler et al.
GYNECOLOGIC ONCOLOGY (2017)
OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer
Alexander A. Svoronos et al.
CANCER RESEARCH (2016)
MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway
Changjun He et al.
ONCOTARGET (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway
Tao Du et al.
MOLECULAR CANCER (2014)
Chemopreventive strategies in hepatocellular carcinoma
Siddharth Singh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers
Wen Zhou et al.
CANCER CELL (2013)
The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer
Ruprecht Kuner et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Tumor-Specific Activation of the C-JUN/MELK Pathway Regulates Glioma Stem Cell Growth in a p53-Dependent Manner
Chunyu Gu et al.
STEM CELLS (2013)
Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?
Uzma Asghar et al.
JOURNAL OF HEPATOLOGY (2012)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Maternal embryonic leucine zipper kinase is stabilized in mitosis by phosphorylation and is partially degraded upon mitotic exit
Caroline Badouel et al.
EXPERIMENTAL CELL RESEARCH (2010)
Hepatocellular carcinoma pathogenesis: from genes to environment
Paraskevi A. Farazi et al.
NATURE REVIEWS CANCER (2006)
Substrate specificity and activity regulation of protein kinase MELK
M Beullens et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation
I Nakano et al.
JOURNAL OF CELL BIOLOGY (2005)
Evaluation of risk factors for nasopharyngeal carcinoma in high-risk nasopharyngeal carcinoma families in Taiwan
XH Yang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Inhibition of spliceosome assembly by the cell cycle-regulated protein kinase MELK and involvement of splicing factor NIPP1
V Vulsteke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Share Paper
